Functional analysis of the p57(KIP2) gene mutation in Beckwith-Wiedemann syndrome

Human Genetics

Volumn 104, Issue 3, 1999, Pages 205-210

  Bhuiyan, Zahurul A ^a   Yatsuki, Hitomi ^b   Sasaguri, Toshiyuki ^a   Joh, Keiichiro ^b   Soejima, Hidenobu ^b   Zhu, Xike ^b   Hatada, Izuho ^a,c   Morisaki, Hiroko ^a   Morisaki, Takayuki ^a   Mukai, Tsunehiro ^a,b  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b SAGA UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CDK2 PROTEIN, HUMAN; CDKN1C PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1C; HYBRID PROTEIN; NUCLEAR PROTEIN; PROTEIN SERINE THREONINE KINASE;

ALLELE; ANIMAL CELL; ARTICLE; BECKWITH WIEDEMANN SYNDROME; CANCER; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CHROMOSOME 11P; CLINICAL ARTICLE; DISEASE ASSOCIATION; GENE MUTATION; HETEROZYGOTE; HUMAN; HUMAN CELL; MOTHER; NONHUMAN; NONSENSE MUTATION; PRIORITY JOURNAL; ANIMAL; CELL NUCLEUS; CELL STRAIN COS1; DRUG ANTAGONISM; ENZYMOLOGY; ESCHERICHIA COLI; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MUTATION; PLASMID;

ANIMALS; BECKWITH-WIEDEMANN SYNDROME; CDC2-CDC28 KINASES; CELL NUCLEUS; COS CELLS; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P57; CYCLIN-DEPENDENT KINASES; ESCHERICHIA COLI; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MUTATION; NUCLEAR PROTEINS; PLASMIDS; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT FUSION PROTEINS;

EID: 0032588015     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390050937     Document Type: Article

References (34)

1. Best LG, Hoekstra RE (1981) Wiedemann-Beckwith syndrome: autosomal dominant inheritance in a family. Am J Hum Genet 9:291-299
2. Boulikas T (1993) Nuclear localization signals (NLS). Crit Revs Eukaryot Gene Expr 3:193-227
3. Caspary T, Cleary MA, Baker CC, Guan X-J, Tilghman SM (1998) Multiple mechanisms regulate imprinting of the mouse distal chromosome 7 gene cluster. Mol Cell Biol 18:3466-3474
4. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816
5. KIP2 in cyclin-dependent kinase 2 inhibition and growth suppression. J Biol Chem 273:16544-16550
6. KIP2, a cyclin dependent kinase inhibitor, in mouse. Nat Genet 11:204-206
7. KIP2 is mutated in Beckwith-Wiedemann syndrome. Nat Genet 14:171-173
8. KIP2 and its reduced expression in Wilms' tumors. Hum Mol Genet 5:783-788
9. KIP2 mutations in Beckwith-Wiedemann syndrome. Hum Genet 100:681-683
10. Henri I, Bonaiti-Pellie C, Chehensse V, Beldjord C, Schwartz C, Utermann G, Junien C (1991) Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature 351:665-667
11. Ishida A, Sasaguri T, Kosaka C, Nojima H, Ogata J (1997) Induction of the cyclin-dependent kinase inhibitor p21Sdi1/Cip1/Waf1 by nitric oxide-generating vasodilator in vascular smooth muscle cells . J Biol Chem 272:10051-10057
12. Koufos A, Grundy P, Morgan K, Aleck KA, Hadro T, Lampkin BC, Kalbakji A, Cavenee WK (1989) Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. Am J Hum Genet 44:711-719
13. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277:680-685
14. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9:639-649
15. KIP2 mutation in Beckwith-Wiedemann syndrome. Am J Hum Genet 61:304-309
16. Mannens M, Hoovers JMN, Redeker E, Verjaal M, Feinberg AP, Little P, Boavida M, et al (1994) Parental imprinting of human chromosome region 11p15.3-pter involved in the Beckwith-Wiedemann syndrome and various human neoplasia. Eur J Hum Genet 2:3-23
17. CIPI Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9:650-662
18. Mikaelian I, Sergeant A (1992) A general and fast method to generate multiple site directed mutation. Nucleic Acids Res 20:376
19. Moutou C, Junien C, Henry I, Bonaiti-Pellie C (1992) Beckwith-Wiedemann syndrome: a demonstration of the mechanisms responsible for the excess of transmitting females. J Med Genet 29:217-220
20. Niikawa N, Ishikiriyama S, Takahashi S, Inagawa A, Tonoki H, Ohta Y, Hase N, Kamei T, Kajii T (1986) The Wiedemann-Beckwith syndrome: pedigree studies on five families. Evidence for autosomal dominant inheritance with variable expressivity. Am J Med Genet 24:41-45
21. Okano Y (1986) An infant with Beckwith-Wiedemann syndrome and chromosomal duplication 11p13-pter: correlation of symptoms between 11p trisomy and Beckwith-Wiedemann syndrome. Jpn J Hum Genet 31:365-372
22. KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors. Am J Hum Genet 61:295-303
23. Ping AJ, Reeve AE, Law DJ, Young MR, Boehnke M, Feinberg AP (1989) Genetic linkage of Beckwith-Wiedemann syndrome to 11p15.5. Am J Hum Genet 44:720-723
24. KIPI, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitotic signals. Cell 78:59-66
25. Pueschel SM, Padre-Mendoza T (1984) Chromosome 11 and Beckwith-Wiedemann syndrome. J Pediatr 102:873-876
26. Raff MC (1996) Size control: the regulation of cell numbers in animal development. Cell 86:173-175
27. Reik W, Maher ER (1997) Imprinting in clusters: lesson from Beckwith-Wiedemann syndrome. Trends Genet 134:330-335
28. Seizinger B, et al (1991) V. Report of the committee on chromosome and gene loss in human neoplasia. Cytogenet Cell Genet 58:1080-1096
29. Toyoshima H, Hunter T (1994) P27, a novel inhibitor of G1 cyclin-Cd1 protein kinase activity, is related to p21. Cell 78:67-74
30. KIP2 requires binding to proliferating cell nuclear antigen. Proc Natl Acad Sci USA 95:1392-1397
31. Waziri M, Patil SR, Hanson JW, Batrley JA (1983) An abnormality of chromosome 11 in patients with features of Beckwith-Wiedemann syndrome. J Pediatr 102:873-876
32. Wiedemann HR (1983) Tumors and hemihypertrophy associated with Wiedemann-Beckwith syndrome. Eur J Pediatr 141:129
33. Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev 11:973-983
34. KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387:151-158